Login

Balance Sheets

In USD, except per-share amounts
Q1 FY2014
As of Dec 31, 2013
Q4 FY2013
As of Sep 30, 2013
Q3 FY2013
As of Jun 30, 2013
Q2 FY2013
As of Mar 31, 2013
Q1 FY2013
As of Dec 31, 2012
Q4 FY2012
As of Sep 30, 2012
Q3 FY2012
As of Jun 30, 2012
Q2 FY2012
As of Mar 31, 2012
Q1 FY2012
As of Dec 31, 2011
Q4 FY2011
As of Sep 30, 2011
CURRENT ASSETS
Cash
Prepaid expenses
TOTAL CURRENT ASSETS
Website, net of amortization
Website, net of amortization
Mineral properties
TOTAL OTHER ASSETS
TOTAL OTHER ASSETS
TOTAL ASSETS
CURRENT LIABILITIES
Accounts payable and accrued liabilities
Accounts payable - related party
Accounts payable related parties
Loans payable
Convertible note payable, net of discount of $46,666 and $10,833
Derivative Liability
TOTAL CURRENT LIAILITIES
TOTAL LIABILITIES
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value, 1,500,000,000 shares authorized; 592,193,622 and 153,004,106 shares issued and outstanding as of December 31, 2013 and September 30, 2013 respectively.
Series C Preffered $0.001 par vlaue, 100,000 shares authorized; 100,000 and 0 shares issued and outstanding as of September 30, 2013 and 2012 respectively
Series C Preffered $0.001 par vlaue, 100,000 shares authorized; 100,000 shares issued and outstanding as of December 31 and September 30, 2013 respectively
Additional paid-in capital
Additional paid-in capital - warrants
Deferred stock based compensation
Stock subscription receivable
Deficit accumulated during the exploration stage
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support